{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:13:41Z","timestamp":1787508821144,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62372144"],"award-info":[{"award-number":["62372144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Outstanding Youth Foundation of Heilongjiang Province of China","award":["YQ2023F004"],"award-info":[{"award-number":["YQ2023F004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13888-2","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:28:06Z","timestamp":1755026886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severity-specific immune landscape of COVID-19 revealed by single-cell sequencing"],"prefix":"10.1038","volume":"15","author":[{"given":"Hongying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"1142","key":"13888_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/postgradmedj-2020-138234","volume":"96","author":"S Umakanthan","year":"2020","unstructured":"Umakanthan, S. et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad. Med. J. 96 (1142), 753\u2013758 (2020).","journal-title":"Postgrad. Med. J."},{"issue":"6","key":"13888_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00134-020-06028-z","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan, Q. et al. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from wuhan, China. Intensive Care Med. 46 (6), 1294\u20131297 (2020).","journal-title":"Intensive Care Med."},{"issue":"10223","key":"13888_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet 395 (10223), 497\u2013506 (2020).","journal-title":"Lancet"},{"issue":"9","key":"13888_CR4","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/cbin.11403","volume":"44","author":"N Fathi","year":"2020","unstructured":"Fathi, N. & Rezaei, N. Lymphopenia in COVID-19: therapeutic opportunities. Cell. Biol. Int. 44 (9), 1792\u20131797 (2020).","journal-title":"Cell. Biol. Int."},{"issue":"13","key":"13888_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. Jama 323 (13), 1239\u20131242 (2020).","journal-title":"Jama"},{"issue":"1","key":"13888_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41392-021-00835-6","volume":"6","author":"JL Zhang","year":"2021","unstructured":"Zhang, J. L. et al. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal. Transduct. Target. Ther. 6 (1), 414 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"13888_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1049\/nbt2.12115","volume":"17","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. scRNA-seq data analysis method to improve analysis performance. IET Nanobiotechnol. 17 (3), 246\u2013256 (2023).","journal-title":"IET Nanobiotechnol."},{"issue":"5","key":"13888_CR8","first-page":"100289","volume":"3","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. Delineating COVID-19 immunological features using single-cell RNA sequencing. Innov. (Camb). 3 (5), 100289 (2022).","journal-title":"Innov. (Camb)"},{"issue":"15-16","key":"13888_CR9","doi-asserted-by":"publisher","first-page":"e2200026","DOI":"10.1002\/pmic.202200026","volume":"22","author":"M Alexovi\u010d","year":"2022","unstructured":"Alexovi\u010d, M. et al. Human peripheral blood mononuclear cells: A review of recent proteomic applications. Proteomics 22 (15-16), e2200026 (2022).","journal-title":"Proteomics"},{"issue":"2","key":"13888_CR10","first-page":"174","volume":"28","author":"AA Rabaan","year":"2020","unstructured":"Rabaan, A. A. et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med. 28 (2), 174\u2013184 (2020).","journal-title":"Infez Med."},{"key":"13888_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"WH Mahallawi","year":"2018","unstructured":"Mahallawi, W. H. et al. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 104, 8\u201313 (2018).","journal-title":"Cytokine"},{"issue":"1","key":"13888_CR12","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.1038\/s41598-023-35731-2","volume":"13","author":"D Langgartner","year":"2023","unstructured":"Langgartner, D. et al. COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs. Sci. Rep. 13 (1), 9496 (2023).","journal-title":"Sci. Rep."},{"issue":"6","key":"13888_CR13","doi-asserted-by":"publisher","first-page":"112613","DOI":"10.1016\/j.celrep.2023.112613","volume":"42","author":"M Potts","year":"2023","unstructured":"Potts, M. et al. Proteomic analysis of Circulating immune cells identifies cellular phenotypes associated with COVID-19 severity. Cell. Rep. 42 (6), 112613 (2023).","journal-title":"Cell. Rep."},{"key":"13888_CR14","doi-asserted-by":"publisher","first-page":"985187","DOI":"10.3389\/fimmu.2022.985187","volume":"13","author":"Y Ren","year":"2022","unstructured":"Ren, Y. et al. Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR\/BCR clonal expansion in a relapsed ovarian cancer patient. Front. Immunol. 13, 985187 (2022).","journal-title":"Front. Immunol."},{"issue":"21","key":"13888_CR15","doi-asserted-by":"publisher","first-page":"24432","DOI":"10.18632\/aging.203695","volume":"13","author":"F Zheng","year":"2021","unstructured":"Zheng, F. et al. Immune cell and TCR\/BCR repertoire profiling in systemic lupus erythematosus patients by single-cell sequencing. Aging (Albany NY). 13 (21), 24432\u201324448 (2021).","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"13888_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41421-021-00321-x","volume":"7","author":"L Luo","year":"2021","unstructured":"Luo, L. et al. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell. Discov. 7 (1), 89 (2021).","journal-title":"Cell. Discov"},{"issue":"11","key":"13888_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/tri.13475","volume":"32","author":"A Minervina","year":"2019","unstructured":"Minervina, A., Pogorelyy, M. & Mamedov, I. T-cell receptor and B-cell receptor repertoire profiling in adaptive immunity. Transpl. Int. 32 (11), 1111\u20131123 (2019).","journal-title":"Transpl. Int."},{"key":"13888_CR18","doi-asserted-by":"publisher","first-page":"102678","DOI":"10.1016\/j.bcmd.2022.102678","volume":"97","author":"H Bai","year":"2022","unstructured":"Bai, H. et al. Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing. Blood Cells Mol. Dis. 97, 102678 (2022).","journal-title":"Blood Cells Mol. Dis."},{"issue":"11","key":"13888_CR19","doi-asserted-by":"publisher","first-page":"e29199","DOI":"10.1002\/jmv.29199","volume":"95","author":"IS Kim","year":"2023","unstructured":"Kim, I. S. et al. Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories. J. Med. Virol. 95 (11), e29199 (2023).","journal-title":"J. Med. Virol."},{"issue":"1","key":"13888_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-020-00263-y","volume":"5","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal. Transduct. Target. Therapy. 5 (1), 156 (2020).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"13888_CR21","doi-asserted-by":"crossref","unstructured":"Huo, L. et al. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects. Brief. Bioinform, 22(6). (2021).","DOI":"10.1093\/bib\/bbab229"},{"key":"13888_CR22","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1016\/j.csbj.2020.10.016","volume":"18","author":"G Luo","year":"2020","unstructured":"Luo, G. et al. Probing infectious disease by single-cell RNA sequencing: progresses and perspectives. Comput. Struct. Biotechnol. J. 18, 2962\u20132971 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"10","key":"13888_CR23","first-page":"e19080","volume":"13","author":"A Parimoo","year":"2021","unstructured":"Parimoo, A. et al. Dynamics of inflammatory markers in predicting mortality in COVID-19. Cureus 13 (10), e19080 (2021).","journal-title":"Cureus"},{"issue":"1","key":"13888_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41467-021-27716-4","volume":"13","author":"A Unterman","year":"2022","unstructured":"Unterman, A. et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat. Commun. 13 (1), 440 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"13888_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using cellchat. Nat. Commun. 12 (1), 1088 (2021).","journal-title":"Nat. Commun."},{"key":"13888_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.copbio.2020.07.010","volume":"65","author":"J Chiffelle","year":"2020","unstructured":"Chiffelle, J. et al. T-cell repertoire analysis and metrics of diversity and clonality. Curr. Opin. Biotechnol. 65, 284\u2013295 (2020).","journal-title":"Curr. Opin. Biotechnol."},{"key":"13888_CR27","doi-asserted-by":"publisher","first-page":"636250","DOI":"10.3389\/fmicb.2021.636250","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun, H. et al. Signatures of B cell receptor repertoire following Pneumocystis infection. Front. Microbiol. 12, 636250 (2021).","journal-title":"Front. Microbiol."},{"issue":"12","key":"13888_CR28","doi-asserted-by":"publisher","first-page":"113450","DOI":"10.1016\/j.celrep.2023.113450","volume":"42","author":"F Matassoli","year":"2023","unstructured":"Matassoli, F. et al. High frequency of HIV precursor-target-specific B cells in sub-Saharan populations. Cell. Rep. 42 (12), 113450 (2023).","journal-title":"Cell. Rep."},{"key":"13888_CR29","doi-asserted-by":"crossref","unstructured":"Sureshchandra, S. et al. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI Insight, 6(24). (2021).","DOI":"10.1172\/jci.insight.153201"},{"issue":"D1","key":"13888_CR30","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu, C. et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 51 (D1), D870\u2013d876 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"13888_CR31","doi-asserted-by":"publisher","first-page":"e12967","DOI":"10.1111\/sji.12967","volume":"93","author":"A Jafarzadeh","year":"2021","unstructured":"Jafarzadeh, A. et al. Lymphopenia an important immunological abnormality in patients with COVID-19: possible mechanisms. Scand. J. Immunol. 93 (2), e12967 (2021).","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"13888_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.14423\/SMJ.0000000000001546","volume":"116","author":"NR Kumar","year":"2023","unstructured":"Kumar, N. R. et al. Convalescent plasma therapy in Late-State, severe COVID-19 infection. South. Med. J. 116 (5), 427\u2013433 (2023).","journal-title":"South. Med. J."},{"key":"13888_CR33","doi-asserted-by":"crossref","unstructured":"Ramasamy, S. & Subbian, S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin. Microbiol. Rev., 34(3). (2021).","DOI":"10.1128\/CMR.00299-20"},{"issue":"3","key":"13888_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/qjmed\/hcac234","volume":"116","author":"JJ Shin","year":"2023","unstructured":"Shin, J. J. et al. MIF is a common genetic determinant of COVID-19 symptomatic infection and severity. Qjm 116 (3), 205\u2013212 (2023).","journal-title":"Qjm"},{"key":"13888_CR35","doi-asserted-by":"publisher","first-page":"1236374","DOI":"10.3389\/fimmu.2023.1236374","volume":"14","author":"J Westmeier","year":"2023","unstructured":"Westmeier, J. et al. Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients. Front. Immunol. 14, 1236374 (2023).","journal-title":"Front. Immunol."},{"issue":"7888","key":"13888_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-04142-6","volume":"600","author":"M Witkowski","year":"2021","unstructured":"Witkowski, M. et al. Untimely TGF\u03b2 responses in COVID-19 limit antiviral functions of NK cells. Nature 600 (7888), 295\u2013301 (2021).","journal-title":"Nature"},{"issue":"69","key":"13888_CR37","doi-asserted-by":"publisher","first-page":"eabi4613","DOI":"10.1126\/sciimmunol.abi4613","volume":"7","author":"JM Moreau","year":"2022","unstructured":"Moreau, J. M. et al. Transforming growth factor-\u03b21 in regulatory T cell biology. Sci. Immunol. 7 (69), eabi4613 (2022).","journal-title":"Sci. Immunol."},{"key":"13888_CR38","doi-asserted-by":"crossref","unstructured":"Ye, Z. et al. Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients. Elife, 13. (2024).","DOI":"10.7554\/eLife.92841"},{"issue":"2","key":"13888_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello, S. M. et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer. 1 (2), 235\u2013248 (2020).","journal-title":"Nat. Cancer"},{"key":"13888_CR40","doi-asserted-by":"crossref","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform, 22(6). (2021).","DOI":"10.1093\/bib\/bbab260"},{"key":"13888_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-0716-4168-2_17","volume":"2862","author":"MA Chhipa","year":"2025","unstructured":"Chhipa, M. A., Sanayhie, S. A. & Sabatinos, S. A. Assessing drug sensitivity in fission yeast using Half-Maximal inhibitory concentration (IC50) assays. Methods Mol. Biol. 2862, 241\u2013253 (2025).","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"13888_CR42","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3855\/jidc.19202","volume":"18","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Paxlovid for the treatment of COVID-19: a systematic review and meta-analysis. J. Infect. Dev. Ctries. 18 (8), 1169\u20131178 (2024).","journal-title":"J. Infect. Dev. Ctries."},{"issue":"7","key":"13888_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jamainternmed.2021.0392","volume":"181","author":"C Yang","year":"2021","unstructured":"Yang, C. & Liu, M. Tocilizumab in treatment for patients with COVID-19. JAMA Intern. Med. 181 (7), 1017\u20131018 (2021).","journal-title":"JAMA Intern. Med."},{"issue":"12","key":"13888_CR44","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","volume":"10","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar, A. P. J. et al. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 10 (12), 1137\u20131146 (2022).","journal-title":"Lancet Respir Med."},{"key":"13888_CR45","unstructured":"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet, 400(10349): pp. 359\u2013368. (2022)."},{"issue":"2","key":"13888_CR46","doi-asserted-by":"publisher","first-page":"e28441","DOI":"10.1002\/jmv.28441","volume":"95","author":"B Amani","year":"2023","unstructured":"Amani, B. & Amani, B. Efficacy and safety of nirmatrelvir\/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis. J. Med. Virol. 95 (2), e28441 (2023).","journal-title":"J. Med. Virol."},{"issue":"7","key":"13888_CR47","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","volume":"2","author":"T Huet","year":"2020","unstructured":"Huet, T. et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2 (7), e393\u2013e400 (2020).","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"13888_CR48","doi-asserted-by":"publisher","first-page":"e2239","DOI":"10.1002\/rmv.2239","volume":"32","author":"T Klopfenstein","year":"2022","unstructured":"Klopfenstein, T. et al. Tocilizumab in COVID-19 pneumonia: practical proposals based on a narrative review of randomised trials. Rev. Med. Virol. 32 (1), e2239 (2022).","journal-title":"Rev. Med. Virol."},{"issue":"5","key":"13888_CR49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0006-2952(02)01619-2","volume":"65","author":"J Catusse","year":"2003","unstructured":"Catusse, J. et al. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochem. Pharmacol. 65 (5), 813\u2013821 (2003).","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"13888_CR50","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tips.2020.06.001","volume":"41","author":"L Gutierrez","year":"2020","unstructured":"Gutierrez, L., Beckford, J. & Alachkar, H. Deciphering the TCR repertoire to solve the COVID-19 mystery. Trends Pharmacol. Sci. 41 (8), 518\u2013530 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"13888_CR51","doi-asserted-by":"publisher","first-page":"102596","DOI":"10.1016\/j.jaut.2021.102596","volume":"118","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J. Autoimmun. 118, 102596 (2021).","journal-title":"J. Autoimmun."},{"issue":"9","key":"13888_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5483\/BMBRep.2022.55.9.077","volume":"55","author":"HY Jo","year":"2022","unstructured":"Jo, H. Y. et al. Establishment of the large-scale longitudinal multi-omics dataset in COVID-19 patients: data profile and biospecimen. BMB Rep. 55 (9), 465\u2013471 (2022).","journal-title":"BMB Rep."},{"key":"13888_CR53","doi-asserted-by":"crossref","unstructured":"Kim, J. W. et al. T-Cell receptor repertoire characteristics associated with prognostic significance in High-Grade serous ovarian carcinoma. Genes (Basel), 14(4). (2023).","DOI":"10.3390\/genes14040785"},{"issue":"6","key":"13888_CR54","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s10875-021-01045-z","volume":"41","author":"CM Chang","year":"2021","unstructured":"Chang, C. M. et al. Profiling of T cell repertoire in SARS-CoV-2-Infected COVID-19 patients between mild disease and pneumonia. J. Clin. Immunol. 41 (6), 1131\u20131145 (2021).","journal-title":"J. Clin. Immunol."},{"key":"13888_CR55","doi-asserted-by":"publisher","first-page":"964976","DOI":"10.3389\/fimmu.2022.964976","volume":"13","author":"F Qi","year":"2022","unstructured":"Qi, F. et al. Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination. Front. Immunol. 13, 964976 (2022).","journal-title":"Front. Immunol."},{"issue":"7","key":"13888_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s13258-022-01261-w","volume":"44","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage. Genes Genomics. 44 (7), 813\u2013822 (2022).","journal-title":"Genes Genomics"},{"issue":"3","key":"13888_CR57","doi-asserted-by":"publisher","first-page":"e29488","DOI":"10.1002\/jmv.29488","volume":"96","author":"J Xiao","year":"2024","unstructured":"Xiao, J. et al. The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers. J. Med. Virol. 96 (3), e29488 (2024).","journal-title":"J. Med. Virol."},{"key":"13888_CR58","doi-asserted-by":"crossref","unstructured":"Hoffmann, M. et al. Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2. bioRxiv, (2023).","DOI":"10.1101\/2023.11.03.564190"},{"issue":"1","key":"13888_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1208\/s12248-020-00532-2","volume":"23","author":"J Majumder","year":"2021","unstructured":"Majumder, J. & Minko, T. Recent developments on therapeutic and diagnostic approaches for COVID-19. Aaps J. 23 (1), 14 (2021).","journal-title":"Aaps J."},{"issue":"2","key":"13888_CR60","doi-asserted-by":"publisher","first-page":"e21245","DOI":"10.1096\/fj.202002512","volume":"35","author":"S Yan","year":"2021","unstructured":"Yan, S. & Wu, G. Is lymphopenia different between SARS and COVID-19 patients? Faseb J. 35 (2), e21245 (2021).","journal-title":"Faseb J."},{"issue":"14","key":"13888_CR61","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185 (14), 2434\u20132451e17 (2022).","journal-title":"Cell"},{"issue":"9","key":"13888_CR62","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1093\/nar\/gkad238","volume":"51","author":"T Havkin-Solomon","year":"2023","unstructured":"Havkin-Solomon, T. et al. Translation regulation of specific mRNAs by RPS26 C-terminal RNA-binding tail integrates energy metabolism and AMPK-mTOR signaling. Nucleic Acids Res. 51 (9), 4415\u20134428 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"13888_CR63","doi-asserted-by":"publisher","first-page":"D199","DOI":"10.1093\/nar\/gkac984","volume":"51","author":"H Zhao","year":"2023","unstructured":"Zhao, H. et al. LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases. Nucleic Acids Res. 51 (D1), D199\u2013d207 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"13888_CR64","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.18632\/aging.204099","volume":"14","author":"HJ Lu","year":"2022","unstructured":"Lu, H. J. et al. The impact of ALDH7A1 variants in oral cancer development and prognosis. Aging (Albany NY). 14 (10), 4556\u20134571 (2022).","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"13888_CR65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93 (1), 250\u2013256 (2021).","journal-title":"J. Med. Virol."},{"key":"13888_CR66","doi-asserted-by":"publisher","first-page":"106239","DOI":"10.1016\/j.rmed.2020.106239","volume":"176","author":"SS Batah","year":"2021","unstructured":"Batah, S. S. & Fabro, A. T. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Respir Med. 176, 106239 (2021).","journal-title":"Respir Med."},{"issue":"1","key":"13888_CR67","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","volume":"9","author":"H Han","year":"2020","unstructured":"Han, H. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 9 (1), 1123\u20131130 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"13888_CR68","doi-asserted-by":"publisher","first-page":"394632022114582","DOI":"10.1177\/03946320221145827","volume":"36","author":"B Zamani","year":"2022","unstructured":"Zamani, B. et al. Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19. Int. J. Immunopathol. Pharmacol. 36, 3946320221145827 (2022).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"13888_CR69","doi-asserted-by":"publisher","first-page":"630767","DOI":"10.3389\/fcvm.2021.630767","volume":"8","author":"CC Law","year":"2021","unstructured":"Law, C. C. et al. Clinical implications of IL-32, IL-34 and IL-37 in atherosclerosis: speculative role in cardiovascular manifestations of COVID-19. Front. Cardiovasc. Med. 8, 630767 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"13888_CR70","doi-asserted-by":"crossref","unstructured":"Galv\u00e1n-Pe\u00f1a, S. et al. Profound Treg perturbations correlate with COVID-19 severity. Proc. Natl. Acad. Sci. U S A, 118(37). (2021).","DOI":"10.1073\/pnas.2111315118"},{"issue":"1","key":"13888_CR71","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41467-023-37368-1","volume":"14","author":"A Santa Cruz","year":"2023","unstructured":"Santa Cruz, A. et al. Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8(+)\u03b27 integrin(+) T cells and anti-SARS-CoV-2 IgA response. Nat. Commun. 14 (1), 1772 (2023).","journal-title":"Nat. Commun."},{"issue":"13","key":"13888_CR72","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/1873-3468.14104","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Serum levels of the IgA isotype switch factor TGF-\u03b21 are elevated in patients with COVID-19. FEBS Lett. 595 (13), 1819\u20131824 (2021).","journal-title":"FEBS Lett."},{"key":"13888_CR73","doi-asserted-by":"crossref","unstructured":"Vaz de Paula, C. B. et al. COVID-19: immunohistochemical analysis of TGF-\u03b2 signaling pathways in pulmonary fibrosis. Int. J. Mol. Sci., 23(1). (2021).","DOI":"10.3390\/ijms23010168"},{"issue":"1","key":"13888_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","volume":"20","author":"Y Cheng","year":"2021","unstructured":"Cheng, Y. et al. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin. Mol. Cancer. 20 (1), 62 (2021).","journal-title":"Mol. Cancer"},{"issue":"6","key":"13888_CR75","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/tan.15158","volume":"102","author":"S Buhler","year":"2023","unstructured":"Buhler, S. et al. HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era. Hla 102 (6), 720\u2013730 (2023).","journal-title":"Hla"},{"issue":"9","key":"13888_CR76","doi-asserted-by":"publisher","first-page":"e30394","DOI":"10.1016\/j.heliyon.2024.e30394","volume":"10","author":"X Peng","year":"2024","unstructured":"Peng, X. et al. Increase in HIV reservoir and T cell immune response after coronavac vaccination in people living with HIV. Heliyon 10 (9), e30394 (2024).","journal-title":"Heliyon"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13888-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:22:32Z","timestamp":1757380952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13888-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13888"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13888-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29596"}}